Literature DB >> 24533578

BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis.

A Chaminade1, H Conte, T Jouary, A Fauconneau, A-S Darrigade, M Beylot-Barry, A Pham-Ledard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24533578     DOI： 10.1111/jdv.12397

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

Review 1.  Systemic vasculitis associated with vemurafenib treatment: Case report and literature review.

Authors:  Adrien Mirouse; Léa Savey; Fanny Domont; Cloé Comarmond; Stéphane Barete; Emmanuelle Plaisier; Philippe Rouvier; Patrice Cacoub; David Saadoun
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

2.  Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect.

Authors:  Miruna Negulescu; Florian Deilhes; Vincent Sibaud; Emilie Tournier; Laurence Lamant; Serge Boulinguez; Nicolas Meyer
Journal:  Case Rep Dermatol       Date:  2017-03-21

Review 3.  Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.

Authors:  Lucie Heinzerling; Thomas K Eigentler; Michael Fluck; Jessica C Hassel; Daniela Heller-Schenck; Jan Leipe; Matthias Pauschinger; Arndt Vogel; Lisa Zimmer; Ralf Gutzmer
Journal:  ESMO Open       Date:  2019-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.